No Data
No Data
Xintiandi (301277.SZ): 2.1 million shares issued before the initial public offering will be lifted on July 15th.
On July 11th, Gelunhui announced a notice about the partial lifting of the restricted shares for the first issuance of public shares. There was only one shareholder for this partial lifting, involving a total of 2.1 million shares, which accounts for 0.7499% of the company's total share capital. The lifting date for the restricted shares is July 15, 2024 (Monday).
Xintian Real Estate Group (00760.HK): The subsidiary Yongxiang received a letter from SHKP
Gelonghui, June 2, 丨 Xintian Real Estate Group (00760.HK) announced that on May 31, 2024, Yongxiang, a wholly-owned subsidiary of the company (holding 30% of Guangzhou Xintian's shares), received a letter from Xindi (a company holding the remaining 70% of Guangzhou Xintian's shares). The letter argues that, according to the terms of the framework agreement, given that (i) Yongxiang is mainly responsible for coordinating the work of the relocation and resettlement area, (ii) the costs related to the relocation and resettlement area paid by Guangzhou Xintian have exceeded the estimated cost at the beginning of the cooperation, and (iii) Xindi, as the holder of 70% of Guangzhou Xintian's shares, has indirectly borne such overspent costs,
Xintiandi (301277.SZ): Pharmaceutical production license changes mainly involve increasing commissioned production
Gelonghui, May 21丨Xintiandi (301277.SZ) announced that the company (hereinafter referred to as the “Company”) recently obtained a “Pharmaceutical Production License” issued by the Henan Drug Administration and agreed to the “Pharmaceutical Production License” change application. This change mainly involves an increase in contract production; other details remain unchanged. Additional commissioned items: Trustee Company: Baizheng Pharmaceutical Co., Ltd.; Commissioned Variety: Moxifloxacin Hydrochloride Tablets (Specification: 0.4g); Commissioned Production Address: No. 3888 Xuyou East Road, Dongcheng District, Xuchang City; Commissioned Production Workshop and Production Line: Tablet Workshop, General Production Line. (Pharmaceuticals only
Xintian Real Estate Group (00760.HK) proposes share capital restructuring
Gelonghui, May 10, 丨 Xintian Real Estate Group (00760.HK) announced that the company proposes to carry out and implement a share capital restructuring, which will involve the following steps: (a) share capital reduction, which will involve reducing the company's issued share capital by canceling HK$0.07 per issued share to reduce the company's issued share capital, so that the face value of each issued share will be reduced from HK$0.08 to HK$0.01; (b) pending and immediately after the share capital reduction, the shares will be split. Unissued shares with a face value of HK$0.08 per share were split into 8 shares per share Face value 0.0
Xintiandi (301277.SZ): No technological achievements have been formed in synthetic biotechnology that can be industrialized
Gelonghui, May 7 | Xintiandi (301277.SZ) said on the investor interactive platform that up to now, the company has not achieved technological achievements that can be industrialized in synthetic biotechnology.
Newland Pharmaceutical Co., Ltd. (SZSE:301277) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
No Data